Adner N, Flink O, Nystrand R, Pihl B, Vegis P
Pharmacia LEO Therapeutics AB, Uppsala, Sweden.
J Parenter Sci Technol. 1991 Mar-Apr;45(2):88-93.
A collaborative study was undertaken to determine the potency in endotoxin Units (EU) and International Units (IU) of a control standard endotoxin, LIF-1. Five laboratories from the Swedish Pharmaceutical Industry participated in the study. As reference preparations, two official standards, USP reference standard endotoxin, EC-5 (expressed in EU) and WHOs international standard endotoxin (expressed in IU), were used. The study was performed using the Limulus Amebocyte Lysate (LAL), gel-clot test. The test protocol included dilutions of the endotoxin in steps of 1:1.25 instead of the conventional 1:2 step dilution method. This gave more precise and standardized results. The content of one vial of LIF-1 (CSE) was calculated to be 22 EU and 16 IU which indicates that 1 EU (USP) corresponds to 0.7 IU (WHO).
开展了一项合作研究,以确定对照标准内毒素LIF-1的内毒素单位(EU)和国际单位(IU)效价。瑞典制药行业的五个实验室参与了该研究。作为参考制剂,使用了两种官方标准,即美国药典参考标准内毒素EC-5(以EU表示)和世界卫生组织国际标准内毒素(以IU表示)。该研究采用鲎试剂(LAL)凝胶凝固试验进行。试验方案包括以1:1.25的步长对内毒素进行稀释,而不是传统的1:2步长稀释法。这产生了更精确和标准化的结果。计算得出一瓶LIF-1(CSE)的含量为22 EU和16 IU,这表明1 EU(美国药典)相当于0.7 IU(世界卫生组织)。